AKT1 and colitis: Furthermore, treatment with OTSSP167, a MELK-selective inhibitor, significantly inhibited ferroptosis and reduced DSS-induced colitis in mice by suppressing the protein kinase B (AKT)/IKK/p65 and extracellular signal-regulated kinase (ERK)/IKK/p65 signaling cascades (106).